Document is current
Any future updates will be listed below
-
Authors
Nurmela, Veera
Schroderus, Anna-Mari
Tiainen, Satu
Kuittinen, Outi
Tenhunen, Olli
Jokimäki, Anna
Suoranta, Sanna
Pasonen-Seppänen, Sanna
Sievänen, Tero
Kinnunen, Tuure
Rönkä, Aino
-
Funding
Funding for this research was provided by:
The Finnish Medical Foundation sr (7074)
Cancer Society of North Savo (20240026)
the Paavo Koistinen Foundation (202300011)
Suomen Kulttuurirahasto
State Research Funding for university-level health Research, Kuopio University Hospital, Wellbeing Service County of North Savo (5654210)
Cancer Foundation of Finland
University of Eastern Finland
- License Information
-
More Information
Article History
Received: 1 March 2026
Accepted: 20 April 2026
First Online: 2 May 2026
Declarations
:
: AR reports personal fees for speaking at symposia or financial support for attending conferences from Amgen, Bristol-Myers Squibb, Merck, Novartis, Pfizer and Roche. ST reports personal fees for speaking at symposia, consulting or financial support for attending conferences from Astra Zeneca, BMS, Merck, MSD, Novartis, Pfizer and Roche. None of the financial support was related to the present study. All other authors declare that they have no competing interests.
